Clinical trials: Personality Disorders
Bipolar Disorder II, Major Depressive Disorder (MDD)
Type D Personality and Life Satisfaction in Bipolar Disorder Type 2 and Major Depressive Disorder
Bipolar Disorder Type II (BD-II) and Major Depressive Disorder (MDD) are common mood disorders associated with substantial psychological distress, impaired functioning, and reduced quality of life.
- Trial name
- NCT07679204
- Where
- Turkey (Türkiye)
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Elazığ Mental Health and Diseases Hospital
Bipolar Disorder (BD)
Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian
The HPS-6 (Hypomanic Personality Scale, 6 item version) could prove to be a valuable candidate for screening measures of high risk individuals.
- Trial name
- NCT07399626
- Testing
- Hypomanic Personality Scale - 6
- Where
- Romania
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Babes-Bolyai University
Bipolar Disorder, Cyclothymia
Calling for Care: Cell Phones for Mood Telemetry in Teens
We will modify our existing VMQ/VADIS mood telemetry software to run on a Motorola platform, and enhance it to collect information on both mood symptoms (currently covered by the VMQ/VADIS) as well as daily life stressors…
- Conditions
- Bipolar Disorder, Cyclothymia, Borderline Personality Disorder
- Trial name
- NCT01083823
- Testing
- Mental health telemetry (MHT)
- Where
- Canada
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Sunnybrook Health Sciences Centre
Healthy
Vasopressin Effects on Human Social Communication
This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes.
- Trial name
- AVP (NCT01327027)
- Testing
- Vasopressin, Arginine, ADH
- Where
- United States
- Volunteers
- 225 people, healthy volunteers welcome
- Sponsor
- Bowdoin College
Borderline Personality Disorder
Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
The objective of Study A is to evaluate the efficacy of risperidone on the 4 behavioral dimensions of Berderline Personality Disorder (BPD)in an open label trial:mood swings, impulsivity, thing difficulties and disturbed…
- Trial name
- NCT00204347
- Testing
- risperidone
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University of Alabama at Birmingham